Verona Pharma (VRNA) Skyrockets: Piper Sandler Doubles Price Target to $160
Verona Pharma (VRNA) is making headlines after Piper Sandler significantly increased its price target from $76 to a whopping $160. This bullish outlook suggests strong confidence in the company's future prospects, prompting investors to re-evaluate their positions. What's driving this surge in optim